The worldwide Erectile Dysfunction (ED) Drug Market had a valuation of USD 4.5 billion in 2022, and it is expected to reach USD 6.74 billion by the year 2032, with a remarkable compound annual growth rate (CAGR) of 4.6% over the forecast period. The primary drivers behind this significant growth in market revenue include the increasing prevalence of ED in males, a growing preference for oral treatments, and heightened awareness among patients regarding the available treatment options. https://www.reportsanddata.com/report-detail/erectile-dysfunction-ed-drug-market